Venomyx Therapeutics' Seed Round

Venomyx Therapeutics raised a round of funding on February 10, 2017. Investors include IndieBio.

Venomyx is creating a universal recombinant antivenom for snakebite. Their portable solution will bring antivenom into the 21st century and make treatment safe, effective, and available to the 5.5 mil…

Articles about Venomyx Therapeutics' Seed Round: